China to Add AstraZeneca’s Tezspire to Health Insurance Scheme
China’s National Healthcare Security Administration says AstraZeneca’s asthma drug Tezspire will be added to the country’s health insurance scheme.
China’s National Healthcare Security Administration says AstraZeneca’s asthma drug Tezspire will be added to the country’s health insurance scheme.